Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention.
Klotz
Laurence
L
University of Toronto, Canada. laurence.klotz@sunnybrook.ca
D018450:Disease Progression; D006801:Humans; D008297:Male; D011159:Population Surveillance / Q000379:methods*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology / Q000628:therapy*; D012307:Risk Factors; D013997:Time Factors
D017430:Prostate-Specific Antigen